Myocardial protection in cardiac surgery: A historical review from the beginning to the current topics

General Thoracic and Cardiovascular Surgery

Volumn 61, Issue 9, 2013, Pages 485-496

  Yamamoto, Hiroshi ^a   Yamamoto, Fumio ^a  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular surgery; Current topics; Historical review; Ischemia; Myocardial protection; Reperfusion

Indexed keywords

ADENOSINE; ADENOSINE PLUS LIDOCAINE; AMILORIDE; CALCIUM CHANNEL BLOCKING AGENT; CARDIOPLEGIC AGENT; CARIPORIDE; ESMOLOL; NICORANDIL; PINACIDIL; POTASSIUM; UNCLASSIFIED DRUG;

BLOOD CARDIOPLEGIA; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CRYSTALLOID CARDIOPLEGIA; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; HUMAN; HYPERTHERMIC THERAPY; INTERMETHOD COMPARISON; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; NONHUMAN; RETROGRADE CARDIOPLEGIA; REVIEW; THERMOREGULATION;

CARDIOPLEGIC SOLUTIONS; HEART ARREST, INDUCED; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIUM;

EID: 84883853578     PISSN: 18636705     EISSN: 18636713     Source Type: Journal    
DOI: 10.1007/s11748-013-0279-4     Document Type: Review

References (135)

1. Cooley DA, Reul GJ, Wukasch DC. Ischemic contracture of the heart: "Stone heart". Am J Cardiol. 1972;29:575-7.
2. Melrose DG, Dreyer B, Bentall HH, Baker JBE. Elective cardiac arrest. Lancet. 1955;2:21-2.
3. Hearse DJ, Garlick PB, Humphrey SM. Ischemic contracture of the myocardium: mechanism and prevention. Am J Cardiol. 1977;39:986-93.
4. Hearse DJ, Braimbridge MV, Jynge P. Principles of cardioplegia, basic concepts. In: Hearse DJ, Braimbridge MV, Jynge P, editors. Protection of the ischemic myocardium: cardioplegia. New York: Raven Press Books, Ltd.; 1981. p. 151-66.
5. Reidemeister JC, Heberer G, Bretschneider HJ. Induced cardiac arrest by sodium and calcium depletion and application of procaine. Intern Surg. 1967;47:535-40.
6. Gay WA Jr, Ebert PA. Functional metabolic and morphologic effects of potassium-induced cardioplegia. Surgery. 1973;74:284-90.
7. Hearse DJ, Stewart DA, Braimbridge MV. Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg. 1978;75:877-85.
8. Bleese N, Döring V, Kalmar P, Pokar H, Polonius MJ, Steiner D, Rodewald G. Intraoperative myocardial protection by cardioplegia in hypothermia. J Thorac Cardiovasc Surg. 1978;75:405-13.
9. Clark RE, Ferguson BA, West PN, Schuchleib RC, Henry PD. Pharmacological preservation of the ischemic heart. Ann Thorac Surrg. 1977;24:307-14.
10. Robb-Nicholsen C, Currie WD, Wechsler AS. Effects of verapamil on myocardial tolerance to ischemic cardiac arrest. Circulation (Suppl I). 1978;58:119-24.
11. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia: the development and utilization of a procedure for the induction of reversible ischemic arrest. Circulation. 1976;54:193-202.
12. Lolley DM, Hewitt RL, Drapanas T. Retroperfusion of the heart with glucose, insulin, and potassium during anoxic arrest. J Thorac Cardiovasc Surg. 1974;67:364-70.
13. Levitsky S, Feinberg H. Protection of the myocardium with high energy solutions. Ann Thorac Surg. 1975;20:86-90.
14. Fey K, Follette D, Livesay J, Nelson R, Bugyl H, DeLand E, Buckberg GD. Effects of membrane stabilization on the safety of hypothermic arrest after aortic cross-clamping. Circulation. 1977;56(Suppl 2):143-7.
15. Hearse DJ, Stewart DA, Braimbridge MV. Myocardial protection during bypass and arrest, a possible hazard with lactate containing infusate. J Thorac Cardiovasc Surg. 1976;72:880-4.
16. Kirsch U, Rodewald G, Kalmar P. Induced ischemic arrest in clinical experience with cardioplegia in open heart surgery. J Thorac Cardiovasc Surg. 1972;63:121-30.
17. Bretschneider HJ, Hübner G, Knoll D, Lohr B, Nordbeck H, Spieckermann PG. Myocardial resistance and tolerance to ischemia. J Cardiovasc Surg. 1975;16:241-60.
18. Hearse DJ, Braimbridge MV, Jynge P. Components of cardioplegic solution. In: Hearse DJ, Braimbridge MV, Jynge P, editors. Protection of the ischemic myocardium: cardioplegia. New York: Raven Press Books, Ltd.; 1981. p. 209-99.
19. Hearse DJ, Braimbridge MV, Jynge P. Cardioplegic solutions in clinical use. In: Hearse DJ, Braimbridge MV, Jynge P, editors. Protection of the ischemic myocardium: cardioplegia. New York: Raven Press Books, Ltd.; 1981. p. 341-52.
20. Lolley DM, Ray JF, Myers WO, Sheldon G, Sautter RD. Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study. Ann Thorac Surg. 1978;26:515-23.
21. Fujita T, Yamamoto F. Present status of cardioplegia in Japan, an analysis of a questionnaire. Nihon Kyobu Geka Gakkai Zasshi. 1986;34:1591-601 (Japanese).
22. Barner HB. Historical aspects and current review of myocardial protection. In: Salerno TA, editor. Warm heart surgery. London: Arnold, a member of the Hodder Headline Group; 1995. p. 1-15.
23. Follette DM, Mulder DG, Maloney JV, Buckberg GD. Advantages of blood cardioplegia over continuous perfusion or intermittent ischemia. J Thorac Cardiovasc Surg. 1978;76:604-17.
24. Flaherty JT, Schaff HV, Goldman RA, Gott VL. Metabolic and functional effects of progress of hypothermia during global ischemia. Am J Physiol Heart Circ Physiol. 1979;236:H839-45.
25. Kaijser L, Jansson E, Schmidt W, Bomfim V. Myocardial energy depletion during profound hypothermic cardioplegia for cardiac operations. J Thorac Cardiovasc Surg. 1985;90:896-900.
26. Menasché P, Kural S, Fauchet B, Lavergne A, Commin P, Bercot N, Touchot B, Georgiopoulos G, Piwnica A. Retrograde coronary sinus perfusion: a safe alternative for insuring cardioplegic delivery in aortic valve surgery. Ann Thorac Surg. 1982;34:647-58.
27. Shiki K, Masuda M, Yonenaga K, Asou T, Tokunaga K. Myocardial distribution of retrograde flow through the coronary sinus of the excised normal canine heart. Ann Thorac Surg. 1986;41:265-71.
28. Stirling MC, McClanahan B, Shott RJ. Distribution of cardioplegic solutions infused antegradely and retogradely in normal canine hearts. J Thorac Cardiovasc Surg. 1989;98:1066-76.
29. Hochberg MS, Austin WG. Selective retrograde coronary venous perfusion. Ann Thorac Surg. 1980;29:578-88.
30. Caldarone CA, Krukenkamp IB, Misare BD, Levitsky S. Perfusion deficits with retrograde warm blood cardioplegia. Ann Thorac Surg. 1994;57:403-6.
31. Salerno TA, Houck JP, Barrozo CA, Panos A, Christakis GT, Abel JG, Lichtenstein SV. Retrograde continuous warm blood cardioplegia: a new concept in myocardial protection. Ann Thorac Surg. 1991;51:245-7.
32. Menasché P, Peynet J, Touchot B, Aziz M, Haydar S, Perez G, Veyssié L, Montenegro J, Bloch G, Piwnica A. Normothermic cardioplegia: is aortic cross-clamping still synonymous of myocardial ischemia? Ann Thorac Surg. 1992;54:472-8.
33. Horsley WS, Whitlark JD, Hall JD, Gott JP, Chih P, Huang AH, Park Y, Jones DP, Guyton RA. Revascularization for acute regional infarct: superior protection with warm blood cardioplegia. Ann Thorac Surg. 1993;56:1228-38.
34. Matsuura H, Lazar HL, Yang SM, Rivers S, Treanor PR, Shemin RJ. Detrimental effects of interrupting warm blood coronary revascularization. J Thorac Cardiovasc Surg. 1993;106:357-61.
35. Clafiore AM, Teodori G, Mezzetti A, Bosco G, Verna AM, Giammarco GD, Lapenna D. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg. 1995;59:398-402.
36. Aldea GS, Hou D, Fonger JD, Shemin RJ. Inhomogeneous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg. 1994;107:499-504.
37. Backberg GD, Salerno TA. Simultaneous antegrade/retrograde cardioplegia: experimental/clinical study of a new cardioprotective technique. In: Salerno TA, editor. Warm heart surgery. London: Arnold, a member of the Hodder Headline Group; 1995. p. 90-8.
38. Teoh KH, Christakis GT, Weisel RD. Accelerated myocardial metabolic recovery with terminal warm blood cardioplegia (hot shot). J Thorac Cardiovasc Surg. 1986;91:888-95.
39. Rosenkranz ER, Okamoto F, Buckberg GD, Vinten-Johansen J, Robertson JM, Bugyi HI. The safety of prolonged aortic clamping with blood cardioplegia. II. Glutamate enrichment in energy depleted hearts. J Thorac Cardiovasc Surg. 1984;88:402-10.
40. Rosenkranz ER, Buckberg GD, Laks H, Mulder DG. Warm induction of cardioplegia with glutamate enriched blood in coronary patients with cardiogenic shock who are dependent on inotropic drugs and intraaortic balloon support. J Thorac Cardiovasc Surg. 1983;86:507-18.
41. Allen BS, Buckberg GD, Schwaiger M, Yeatman L, Tillisch J, Kawata N, Messenger J, Lee C. Studies of controlled reperfusion after Ischemia. XVI. Early recovery of regional wall motion in patients following surgical revascularization after eight hours of acute coronary occlusion. J Thorac Cardiovasc Surg. 1986;92:636-48.
42. Laks H, Rosenkranz E, Buckberg GD. Surgical treatment of cardiogenic shock after myocardial infarction. Circulation. 1986;74(Suppl III):16-22.
43. Lichtenstein SV, Ashe KA, el Dalati H, Cusimano RJ, Panos A, Slutsky AS. Warm heart surgery. J Thorac Cardiovasc Surg. 1991;101:269-74.
44. Lichtenstein SV, Abel JG, Salerno TA. Warm heart surgery and results of operation for recent myocardial infarction. Ann Thorac Surg. 1991;52:455-60.
45. Yau TM, Weisel RD, Mickle DAG. Optimal delivery of blood cardioplegia. Circulation. 1991;84(Suppl III):380-8.
46. Yau TM, Ikonomidis JS, Weisel RD, Mickle DAG, Ivanov J, Mohabeer MK, Tumiati L, Carson S, Liu P. Ventricular function after normothermic versus hypothermic cardioplegia. J Thorac Cardiovasc Surg. 1993;105:833-44.
47. Ikonomidis JS, Yau TM, Weisel RD, Hayashida N, Fu X, Comeda M, Ivanov J, Carson S, Mohabeer MK, Tumiati L, Mickle DAG. Optimal flow rates for retrograde warm cardioplegia. J Thorac Cardiovasc Surg. 1994;107:510-9.
48. Hayashida N, Ikonomidis JS, Weisel RD, Shirai T, Ivanov J, Carson SM, Mohabeer MK, Tumiati LC, Mickle DAG. The optimal cardioplegic temperature. Ann Thorac Surg. 1994;58:961-71.
49. Buckberg GD. Update on techniques of myocardial protection. Ann Thorac Surg. 1995;60:805-14.
50. Menasché P, Fleury JP, Veyssié L, Le Dref O, Touchot B, Piwnica AH, Bloch G. Limitation of vasodilation associated with warm heart operation by a "Mini-cardioplegia" delivery technique. Ann Thorac Surg. 1993;56:1148-53.
51. El-Hamamsy I, Stevens LM, Pellerin M, Bouchard D, Pagé P, Carrier M, Perrault LP. A prospective randomized study of diluted versus non-diluted cardioplegia (minicardioplegia) in primary coronary artery bypass surgery. J Cardiovasc Surg. 2004;45:101-6.
52. Albacker TB, Chaturvedi R, Al Kindi AH, Al-Habib H, Al-Atassi T, de Varennes B, Lachapelle K. The effect of using microplegia on perioperative morbidity and mortality in elderly patients undergoing cardiac surgery. Interac Cardiovasc Thorac Surg. 2009;9:56-60.
53. Onorati F, Santini F, Dandale R, Ucci G, Pechlivanidis K, Menon T, Chiomonto B, Mazzucco A, Faggian G. "Polarizing" microplegia improves cardiac cycle efficiency after CABG for unstable angina. Int J Cardiol. 2012;. doi: 10.1016/j.ijcard.2012.06.099.
54. Denis SC, Gevers W, Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol. 1991;23:1077-86.
55. Pike MM, Kitakaze M, Marban E. 23Na-NMR measurements of intracellular sodium in intact perfused ferret hearts during ischemia and reperfusion. Am J Physiol. 1990;259:H1767-73.
56. Yamamoto F, Manning AS, Braimbridge MV, Hearse DJ. Cardioplegia and slow calcium-channel blockers. Studies with verapamil. J Thorac Cardiovasc Surg. 1983;86:252-61.
57. + exchange. Am J Physiol. 1988;255:H608-15.
58. 2+ overload in isolated perfused rabbit heart. Circulation. 1994;89:2787-98.
59. Koike A, Akita T, Hotta Y, Takeya K, Kodama I, Murase M, Abe T, Toyama J. Protective effects of dimethyl amiloride against postischemic myocardial dysfunction in rabbit hearts: phosphorus 31-nuclear magnetic resonance measurements of intracellular pH and cellular energy. J Thorac Cardiovasc Surg. 1996;112:765-75.
60. Choy IO, Schepkin VD, Budinger TF, Obayashi DY, Young JN, DeCampli WM. Effects of specific sodium/hydrogen exchange inhibitor during cardioplegic arrest. Ann Thorac Surg. 1997;64:94-9.
61. Cox CS Jr, Sauer H, Allen SJ, Buja LM, Laine GA. Sodium/hydrogen- exchanger inhibition during cardioplegic arrest and cardiopulmonary bypass: an experimental study. J Thorac Cardiovasc Surg. 2002;123:959-66.
62. + exchange inhibition during pretreatment or during controlled reperfusion supplementation. Ann Thorac Surg. 2003;75:1238-45.
63. + exchange inhibition in hypertrophied myocardium subjected to cardioplegic arrest: an effective cardioprotective approach. Eur J Cardiothorac Surg. 2005;27:111-6.
64. Kitakaze M, Weisfeldt ML, Marban E. Acidosis during early reperfusion prevents myocardial stunning in perfused ferret hearts. J Clin Invest. 1988;82:920-7.
65. Hori M, Kitakaze M, Sato H. Staged reperfusion attenuates myocardial stunning in dogs: role of acidosis during early reperfusion. Circulation. 1991;84:2135-45.
66. Harada K, Flankin A, Joohnson RG, Grossman W, Morgan JP. Acidemia and hypernatremia enhance postischemic recovery of excitation-contraction coupling. Circ Res. 1994;74:1197-209.
67. Ohashi T, Yamamoto F, Yamamoto H, Ichikawa H, Shibata T, Kawashima Y. Transient reperfusion with acidic solution affects postischemic functional recovery: studies in the isolated working rat heart. J Thorac Cardiovasc Surg. 1996;111(3):613-20.
68. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 1993;27:915-24.
69. Boyce SW, Bartels C, Bolli R, Chaitman B, Chen C, Chi E, Jessel A, Kereiakes D, Knight J, Thulin L, Theroux P, on behalf of GUARDIAN Study investigators. Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg. 2003;126:420-7.
70. Mentzer RM Jr, Bartels C, Bolli R, Boyce S, Buckberg GD, Chaitman B, Haverich A, Knight J, Menasché P, Myers ML, Nicolau J, Simoons M, Thulin L, Weisel RD, on behalf of the EXPEDITION Study investigators. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg. 2008;85:1261-70.
71. Cole WC, McPherson CD, Sontag D. ATP-regulated K+ channels protect the myocardium against ischemia-reperfusion damage. Circ Res. 1991;69:571-81.
72. + channels involves high-energy phosphate preservation. Am J Physiol. 1993;265:H1809-18.
73. Lawton JS, Harrington GC, Allen CT, Hsia PW, Damiano RJ Jr. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg. 1996;61:1680-8.
74. Sato T, Sasaki N, O'Rourke B, Marbán E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-8.
75. ATP channels. Eur J Cardiothorac Surg. 2006;30:256-62.
76. Steensrud T, Nordhaug OP, Elvences C, Korvald C, Sørlie DG. Superior myocardial protection with nicorandil cardioplegia. Eur J Cardiothorac Surg. 2003;23:670-7.
77. Kobayashi S, Yoshikawa Y, Sakata S, Takenaka C, Hagihara H, Ohga Y, Abe T, Taniguchi S, Takaki M. Left ventricular mechanoenergetics after hyperpolarized cardioplegic arrest by nicorandil and after depolarized cardioplegic arrest by KCl. Am J Physiol. 2004;287:H1072-80.
78. Steensrud T, Müller S, Endresen PC, Sørlie DG. Clinical testing of nicorandil supplemented normokalemic cardioplegic solution. Interact Cardiovasc Thorac Surg. 2006;5:521-5.
79. Yamamoto S, Yamada T, Kotake Y, Takeda J. Cardioprotective effects of nicorandil in patients undergoing on-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2008;22:548-53.
80. Opie LH. Receptors and signal transduction. In: Opie LH, editor. The heart, physiology, from cell to circulation, 3rd edition. Philadelphia: Lippincott-Raven Publishers; 1998. p. 173-207.
81. Schubert T, Vetter H, Owen P, Reichart B, Opie LH. Adenosine cardioplegia. J Thorac Cardiovasc Surg. 1989;98:1057-65.
82. Mentzer RM Jr, Birjinuk V, Khuri S, Lowe JE, Rahko PS, Weisel RD, Welions HA, Barker ML, Lasley RD, for the Adenosine Myocardial Protection Investigators. Adenosine myocardial protection. Preliminary results of a phase II clinical trial. Ann Surg. 1999;229:643-50.
83. Liu R, Xing J, Miao N, Li W, Liu W, Lai YQ, Luo Y, Ji B. The myocardial protective effect of adenosine as an adjunct to intermittent blood cardioplegia during open heart surgery. Eur J Cardiothoracic Surg. 2009;36:1018-23.
84. Ahlsson A, Sobrosa C, Kaijser L, Jansson E, Bomfim V. Adenosine in cold blood cardioplegia. A placebo-controlled study. Interact Cardiovasc Thorac Surg. 2011;14:48-55.
85. Dobson GP, Jones MW. Adenosine and lidocaine: a new concept in nonpolarizing surgical myocardial arrest, protection and preservation. J Thorac Cardiovasc Surg. 2004;127:794-805.
86. Sloots KL, Vinten-Johansen J, Dobson GP. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery. J Thorac Cardiovasc Surg. 2007;133:1171-8.
87. Corvera JS, Kin H, Dobson GP, Kerendi F, Halkos ME, Katzmark S, Payne CS, Zhao ZQ, Guyton RA, Vinten-Johansen J. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg. 2005;129:599-606.
88. Sloots KL, Dobson GP. Normokalemic adenosine-lidocaine cardioplegia: importance of maintaining a polarized myocardium for optimal arrest and reanimation. J Thorac Cardiovasc Surg. 2010;139:1576-86.
89. Shi W, Jiang R, Dobson GP, Granfeldt A, Vinten-Johansen J. The nondepolarizing, normokalemic cardioplegia formulation adenosine-lidocaine (adenocaine) exerts anti-neutrophil effects by synergistic actions of its components. J Thorac Cardiovasc Surg. 2012;143:1167-75.
90. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res. 2010;87:552-60.
91. Hohnloser SH, Meinertz T, Klingenheben T, Sydow B, Just H. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group. Am J Cardiol. 1991;67:1319-23.
92. Warters RD, Allen SJ, Davis KL, Geissler HJ, Bischoff I, Mutschler E, Mehlhorn U. β-Blockade as an alternative to cardioplegic arrest during cardiopulmonary bypass. Ann Thorac Surg. 1998;65:961-6.
93. Pirk J, Kellovský P. An alternative to cardioplegia. Ann Thorac Surg. 1995;60:464-5.
94. Kuhn-Régnier F, Natour E, Dhein S, Dapunt O, Geissler HJ, LaRosé K, Görg C, Mehlhorn U. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg. 1999;15:67-74.
95. Scorsin M, Mebazaa A, Attar NA, Medini B, Callebert J, Raffoul R, Ramadan R, Maillet JM, Ruffenach A, Simoneau F, Nataf P, Payen D, Lessana A. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Thorac Cardiovasc Surg. 2003;125:1022-9.
96. Borowski A, Raji MR, Eichstaedt HC, Schickendantz S, Korb H. Myocardial protection by pressure- and volume-controlled continuous hypothermic coronary perfusion in combination with esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. Eur J Cardiothoracic Surg. 1998;14:243-9.
97. Bessho R, Chambers DJ. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg. 2002;124:340-51.
98. Fujii M, Chambers DJ. Cardioprotection with esmolol cardioplegia: efficacy as a blood-based solution. Eur J Cardiothoracic Surg. 2012;. doi: 10.1093/ejcts/ezs365.
99. Ede M, Ye J, Gregorash L, Summers R, Pargaonkar S, LeHouerou D, Lessana A, Salerno TA, Deslauriers R. β-Blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg. 1997;63:721-7.
100. Fannelop T, Dahle GO, Matre K, Moen CA, Mongstad A, Eliassen F, Segadal L, Grong K. Esmolol before 80 min of cardiac arrest with oxygenated cold blood cardioplegia alleviates systolic dysfunction. Eur J Cardiothorac Surg. 2008;33:9-17.
101. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone ED, Kirklin JW. Complement activation during cardiopulmonary bypass. Evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med. 1981;304:497-503.
102. Kirklin JK, Westaby S, Blackstone ED, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1983;86:845-57.
103. Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg. 1993;55:552-9.
104. Chello M, Mastroroberto P, Rossana R, Ascione R, Pantaleo D, Amicis VD. Complement and neutrophil activation during cardiopuklmonary bypass. A randomized comparison of hypothermic and normothermic circulation. Eur J Cardiothorac Surg. 1997;11:162-8.
105. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Role of the terminal complement components and inhibition by anti-C5 therapy. Circulation. 1998;97:2259-67.
106. Carrier M, Ménasché P, Levy JH, Taylor KM, Haverich A, Chen JC, Sheman SK, Van de Werf F, Van der Laan M, Todaro TG, Adams PX, Verrier ED. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2006;131:352-6.
107. Testa L, Van Gaal WJ, Bhindi R, Biondi-zoccai GGL, Abbate A, Agostoni P, Porto I, Andreotti F, Crea F, Banning AP. Pexelizumab in ischemic heart disease: a systematic review and meta-analysis on 15,196 patients. J Thorac Cardiovasc Surg. 2008;136:884-93.
108. Sawa Y, Matsuda H, Shimazaki Y, Kaneko M, Nishimura M, Amemiya A, Sakai K, Nakano S. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting. J Thorac Cardiovasc Surg. 1994;108:1125-31.
109. Palatianos GM, Balentine G, Papadakis EG, Triantafillou CD, Vassili MI, Lidoriki A, Dinopoulos A, Astras GM. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg. 2004;77:956-61.
110. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wittwer T, Dörge H, Stamm C, Wassmer G, Wahlers T. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30000 patients. Eur Heart J. 2008;29:1548-59.
111. Braathen B, Jeppsson A, Scherstén H, Hagen OM, Vengen Ø, Rexius H, Lepore V, Tønnessen T. One single dose of histidine-tryptophan- ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: a prospective randomized study. J Thorac Cardiovasc Surg. 2011;141:995-1001.
112. Sezai A, Wakui S, Akiyama K, Hata M, Yoshitake I, Unosawa S, Shiono M. Myocardial protective effect of human atrial natriuretic peptide in cardiac surgery. "hANP shot" in clinical safety trial. Circ J. 2011;75:2144-50.
113. Osaka S, Sezai A, Wakui S, Shimura K, Taniguchi Y, Hata M, Shiono M. Experimental investigation of "hANP shot" using human atrial natriuretic peptide for myocardial protection in cardiac surgery. J Cardiol. 2012;60:66-71.
114. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
115. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev. 2003;83:1113-51.
116. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 1993;342:276-7.
117. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart. 1997;77:314-8.
118. Walsh SR, Tang TY, Kullar P, Jenkins DP, Dutka DP, Gaunt ME. Ischaemic preconditioning during cardiac surgery: systematic review and meta-analysis of perioperative outcomes in randomised clinical trials. Eur J Cardiothorac Surg. 2008;34:985-94.
119. Apostolakis E, Baikoussis NG, Papakonstantinou NA. The role of myocardial ischaemic preconditioning during beating heart surgery: biological aspect and clinical outcome. Interact Cardiovasc Thorac Surg. 2012;14:68-71.
120. Przylenk K, Bauer B, Ovize M, Kloner RA, Whittaker P. Regional ischemic 'Preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87:893-9.
121. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance. Reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997;96:1641-6.
122. Günaydin B, Çakici I, Soncul H, Kalaycioǧlu S, Çevik C, Sancak B, Knzik I, Karadenizli Y. Does remote organ ischaemia trigger cardiac preconditioning during coronary artery surgery? Pharmacol Res. 2000;41:493-6.
123. Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmit MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106:2881-3.
124. Cheung MMH, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery. First clinical application in humans. J Am Coll Cardiol. 2006;47:2277-82.
125. Venugopal V, Hausenloy DJ, Ludman A, Salvo CD, Kolvekar S, Yap J, Lawrence D, Bognolo J, Yellon DM. Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomized controlled trial. Heart. 2009;95:1567-71.
126. Hong DM, Jeon Y, Lee CS, Kim HJ, Lee JM, Bahk JH, Kim KB, Hwang HY. Effects of remote ischemic preconditioning with postconditioning in patients undergoing off-pump coronary artery bypass surgery. Randomized controlled trial. Circ J. 2012;76:884-90.
127. Marczak J, Nowicki R, Kulbacka J, Saczko J. Is remote ischaemic preconditioning of benefit to patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2012;14:634-9.
128. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579-88.
129. Shinohara G, Morita K, Nagahori R, Koh Y, Kinouchi K, Abe T, Hashimoto K. Ischemic postconditioning promotes left ventricular functional recovery after cardioplegic arrest in an in vivo piglet model of global ischemia reperfusion injury on cardiopulmonary bypass. J Thoracic Cardiovasc Surg. 2011;142:926-32.
130. Zhao ZQ, Vinten-Johansen J. Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res. 2006;70:200-11.
131. Li B, Chen R, Huang R, Luo W. Clinical benefit of cardiac ischemic postconditioning in corrections of tetralogy of Fallot. Interact Cardiovasc Thorac Surg. 2009;8:17-21.
132. Luo W, Li B, Chen R, Huang R, Lin G. Effects of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg. 2012;14:634-9.
133. Hagége AA, Marolleau JP, Vilquin JT, Alhéritière A, Peyrard S, Duboc D, Abergel E, Messas E, Mousseaux E, Schwartz K, Desnos M, Menasché P. Skeletal myoblast transplantation in ischemic heart failure. Long-term follow-up of the first phase I cohort of patients. Circulation. 2006;114(Suppl I):I-108-13.
134. Menasché P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagége AA. The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial. Circulation. 2008;117:1189-200.
135. Sawa Y, Miyagawa S, Sakaguchi T, Fujita T, Matsumiya A, Saito A, Shimizu T, Okano T. Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case. Surg Today. 2012;42:181-4.